Shockwave Medical Future Growth
Future criteria checks 3/6
Shockwave Medical is forecast to grow earnings and revenue by 18.4% and 16.3% per annum respectively. EPS is expected to grow by 16.3% per annum. Return on equity is forecast to be 18.8% in 3 years.
Key information
18.4%
Earnings growth rate
16.3%
EPS growth rate
| Medical Equipment earnings growth | 17.1% |
| Revenue growth rate | 16.3% |
| Future return on equity | 18.8% |
| Analyst coverage | Good |
| Last updated | 28 May 2024 |
Recent future growth updates
Recent updates
Shockwave Medical, Inc.'s (NASDAQ:SWAV) 28% Jump Shows Its Popularity With Investors
Apr 06
Is Now An Opportune Moment To Examine Shockwave Medical, Inc. (NASDAQ:SWAV)?
Mar 24Shockwave Medical: Opening Arteries, Delivering Returns
Feb 28Shockwave Medical, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Feb 18There's Been No Shortage Of Growth Recently For Shockwave Medical's (NASDAQ:SWAV) Returns On Capital
Feb 06Calculating The Fair Value Of Shockwave Medical, Inc. (NASDAQ:SWAV)
Jan 24Some Shareholders Feeling Restless Over Shockwave Medical, Inc.'s (NASDAQ:SWAV) P/E Ratio
Jan 09Is Shockwave Medical (NASDAQ:SWAV) A Risky Investment?
Dec 27Do Shockwave Medical's (NASDAQ:SWAV) Earnings Warrant Your Attention?
Dec 13What Is Shockwave Medical, Inc.'s (NASDAQ:SWAV) Share Price Doing?
Nov 17Is Shockwave Medical, Inc. (NASDAQ:SWAV) Trading At A 50% Discount?
Oct 19Shockwave Medical (NASDAQ:SWAV) Is Very Good At Capital Allocation
Oct 06Shockwave Medical (NASDAQ:SWAV) Has A Rock Solid Balance Sheet
Sep 20Do Shockwave Medical's (NASDAQ:SWAV) Earnings Warrant Your Attention?
Sep 07When Should You Buy Shockwave Medical, Inc. (NASDAQ:SWAV)?
Jul 10We Think Shockwave Medical (NASDAQ:SWAV) Might Have The DNA Of A Multi-Bagger
Jun 26We Think Shockwave Medical (NASDAQ:SWAV) Can Manage Its Debt With Ease
Jun 13Is Now The Time To Put Shockwave Medical (NASDAQ:SWAV) On Your Watchlist?
May 29Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,357 | 299 | 318 | 366 | 9 |
| 12/31/2025 | 1,136 | 242 | 239 | 260 | 13 |
| 12/31/2024 | 929 | 210 | 417 | 265 | 7 |
| 3/31/2024 | 788 | 163 | 166 | 198 | N/A |
| 12/31/2023 | 730 | 147 | 165 | 196 | N/A |
| 9/30/2023 | 671 | 244 | 143 | 177 | N/A |
| 6/30/2023 | 617 | 244 | 126 | 161 | N/A |
| 3/31/2023 | 557 | 241 | 121 | 150 | N/A |
| 12/31/2022 | 490 | 216 | 93 | 118 | N/A |
| 9/30/2022 | 430 | 88 | 69 | 86 | N/A |
| 6/30/2022 | 364 | 55 | 48 | 61 | N/A |
| 3/31/2022 | 299 | 29 | 23 | 34 | N/A |
| 12/31/2021 | 237 | -9 | 3 | 15 | N/A |
| 9/30/2021 | 176 | -38 | -29 | -18 | N/A |
| 6/30/2021 | 130 | -53 | -53 | -44 | N/A |
| 3/31/2021 | 84 | -71 | -75 | -64 | N/A |
| 12/31/2020 | 68 | -66 | -83 | -71 | N/A |
| 9/30/2020 | 59 | -65 | -83 | -71 | N/A |
| 6/30/2020 | 51 | -65 | -77 | -66 | N/A |
| 3/31/2020 | 51 | -57 | -66 | -58 | N/A |
| 12/31/2019 | 43 | -51 | -52 | -48 | N/A |
| 9/30/2019 | 34 | -48 | -48 | -45 | N/A |
| 6/30/2019 | 26 | -45 | -47 | -45 | N/A |
| 3/31/2019 | 18 | -44 | -47 | -45 | N/A |
| 12/31/2018 | 12 | -41 | -43 | -41 | N/A |
| 12/31/2017 | 2 | -31 | N/A | -30 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SWAV's forecast earnings growth (18.4% per year) is above the savings rate (2.4%).
Earnings vs Market: SWAV's earnings (18.4% per year) are forecast to grow faster than the US market (14.7% per year).
High Growth Earnings: SWAV's earnings are forecast to grow, but not significantly.
Revenue vs Market: SWAV's revenue (16.3% per year) is forecast to grow faster than the US market (8.5% per year).
High Growth Revenue: SWAV's revenue (16.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SWAV's Return on Equity is forecast to be low in 3 years time (18.8%).